BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kok VC, Wu SC, Lee CK. Successful Remission of Hemolytic-Uremic Syndrome During the Third-line Weekly Gemcitabine for Metastatic Breast Cancer. Breast Cancer (Auckl) 2014;8:57-9. [PMID: 24701120 DOI: 10.4137/BCBCR.S14920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Takabatake D, Oishi K. Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature review. Springerplus 2016;5:684. [PMID: 27350919 DOI: 10.1186/s40064-016-2312-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
2 Krishnappa V, Gupta M, Shah H, Das A, Tanphaichitr N, Novak R, Raina R. The use of eculizumab in gemcitabine induced thrombotic microangiopathy. BMC Nephrol 2018;19:9. [PMID: 29329518 DOI: 10.1186/s12882-018-0812-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]